Hospital and environmental transmission of XDR Salmonella Isangi revealed by genomic Surveillance in Malawi and South Africa

Genomic surveillance in Malawi and South Africa reveals that a specific XDR Salmonella Isangi ST335 clade drives hospital outbreaks through environmental persistence and inter-hospital transmission, posing a significant future threat due to its potential to transfer resistance genes to dominant invasive serovars.

The Gist

Imagine a microscopic "super-villain" bacteria called Salmonella Isangi. For decades, it has been a bit of a mystery, popping up occasionally in hospitals around the world but never getting the full spotlight. However, recently, this villain decided to get really, really dangerous, and two countries—Malawi and South Africa—found themselves in the middle of a high-stakes detective story to figure out what was going on.

Here is the story of that investigation, told in simple terms.

The Villain: A "Super-Bug" with a New Identity

Usually, Salmonella is the kind of bacteria you get from bad food (like undercooked chicken). But this specific type, Salmonella Isangi, has been causing trouble inside hospitals, infecting patients who are already sick.

The real problem? This bacteria has become Extensively Drug-Resistant (XDR). Think of it like a burglar who has learned to pick every lock, bypass every alarm, and ignore every security guard. Doctors have very few antibiotics left that can kill it. In fact, for many patients in Malawi, there are no effective medicines available in their local hospitals.

The Two Crime Scenes: Malawi and South Africa

The researchers looked at two separate "crime scenes" where this bacteria was running wild.

1. The Malawi Mystery: The "Leaky Pipe" Theory
In Malawi, the bacteria was found in a hospital's neonatal unit (where newborns are kept). It was infecting babies who had never even left the hospital.

• The Clue: The scientists didn't just look at the sick babies; they looked everywhere. They found the exact same bacteria on sinks, on cots, on oxygen machines, and even in the rivers flowing right next to the hospital.
• The Metaphor: Imagine the hospital is a house with a leaky pipe. The bacteria was leaking out of the hospital, contaminating the water in the river, and then the river water was flowing back into the hospital system, infecting more people. It was a closed loop where the environment and the hospital were feeding each other.

2. The South Africa Mystery: The "Passing the Buck" Theory
In South Africa, the bacteria was spreading across five different hospitals.

• The Clue: Patients were being moved from one hospital to another. When they arrived at the new hospital, they were carrying the bacteria with them, even if they didn't look sick yet.
• The Metaphor: Think of it like a game of "hot potato." The bacteria was being passed from Hospital A to Hospital B to Hospital C via patients. Because the hospitals didn't realize the patients were carrying it, the bacteria kept spreading to new locations.

The Secret Weapon: The Genetic "Backpack"

The most fascinating part of the story is how this bacteria got so tough.

The bacteria in Malawi and South Africa were almost identical twins, but they were wearing different "backpacks" (plasmids).

• The Backpacks: These are tiny, circular pieces of DNA that bacteria carry. They act like backpacks holding the tools needed to survive antibiotics.
• The Swap: The Malawi bacteria had a backpack made of one material (IncHI2), while the South Africa bacteria had a different one (IncC). Yet, both backpacks contained the exact same "weapons" (resistance genes).
• The Magic Trick: The scientists think these bacteria performed a genetic magic trick. They likely fused their backpacks together temporarily (like zipping two bags into one giant super-bag), swapped the weapons, and then unzipped them again. This allowed the bacteria to share their super-powers even though they were in different places.

The Twist: Strong but Weak?

Here is a strange twist. When the scientists tested this bacteria in mice, it turned out to be less deadly than the common Salmonella that causes food poisoning.

• The Analogy: Imagine a tank that is incredibly well-armored (resistant to drugs) but has a slow engine (less virulent). It can survive in harsh conditions (like a hospital with bleach and strong cleaners) and hide in the environment for a long time, but it doesn't attack the host as aggressively as other bacteria.
• Why it matters: Even though it's "slower" at killing, its ability to hide in sinks, rivers, and on surfaces makes it a persistent nightmare for hospitals. It's the ultimate survivor.

The Big Picture: Why Should We Care?

This study sounds a loud alarm bell for two reasons:

1. The Threat is Real: This bacteria is now a major threat in Africa because it can survive in hospitals and the environment, and we can't easily kill it with medicine.
2. The Danger of Sharing: The biggest fear isn't just that this bacteria will spread, but that it might share its "super-backpack" with other, more common bacteria (like the ones that cause Typhoid fever). If the common bacteria steal these drug-resistance genes, we could lose our ability to treat common infections entirely.

The Missing Piece: The Surveillance Gap

The study highlights a sad inequality. South Africa has a strong system to track these bacteria (like having a high-tech security camera system). Malawi, however, relies on research partnerships to find these outbreaks. Without a national "security camera" system in poorer countries, these super-bugs can spread silently until it's too late.

In short: This paper tells us that a tough, drug-resistant bacteria is hiding in hospitals and rivers, swapping genetic tools to get even stronger, and we need better global teamwork to catch it before it becomes an unstoppable global threat.

Technical Summary

1. Problem Statement

Invasive non-typhoidal Salmonella (iNTS) is a major cause of mortality in Africa, typically dominated by S. Typhimurium and S. Enteritidis. However, Salmonella Isangi is an under-characterized serovar associated with recurrent, antimicrobial-resistant hospital outbreaks.

• The Crisis: Two distinct outbreaks of Extensively Drug-Resistant (XDR) S. Isangi occurred in close succession: one in a hospital in Malawi (2018–2023) and a multi-center nosocomial outbreak in South Africa (2022).
• The Knowledge Gap: Prior to this study, transmission routes, environmental reservoirs, and the specific mechanisms of resistance acquisition for S. Isangi were poorly understood. There was a critical lack of genomic surveillance in low-income settings like Malawi compared to South Africa.

2. Methodology

The study employed a multi-faceted approach combining epidemiology, phenotypic characterization, and high-resolution genomics.

• Data Collection:
  • Malawi: Integrated blood/CSF culture surveillance at Queen Elizabeth Central Hospital (QECH) with environmental sampling from neonatal wards (sinks, cots, devices) and urban river water/wastewater in Blantyre.
  • South Africa: Analyzed isolates from a regional outbreak involving five hospitals in the Eastern Cape and KwaZulu-Natal.
  • Global Context: Retrieved 281 publicly available S. Isangi genomes from EnteroBase and NCBI (as of April 2024).
• Genomic Analysis:
  • Sequencing: Used Illumina (short-read) and Oxford Nanopore MinION (long-read) technologies.
  • Bioinformatics: Performed de novo assembly, SNP calling (GATK), recombination filtering (Gubbins), and phylogenetic reconstruction (RAxML-NG).
  • Plasmid Analysis: Utilized long-read sequencing to circularize plasmids and construct sequence-similarity networks to track resistance gene transfer.
  • Population Structure: Analyzed using RHierBAPS to define lineages.
• Phenotypic Assays:
  • Biofilm: Quantified biofilm formation and cellulose/curli expression compared to S. Typhimurium.
  • Virulence: Tested in vivo virulence and chronic carriage in BALB/c mice.
  • Disinfectant Susceptibility: Determined Minimum Inhibitory Concentrations (MICs) for bleach, chlorine, and chlorhexidine.

3. Key Contributions

• First Comprehensive Characterization: This is the most detailed study of S. Isangi to date, integrating clinical, environmental, and genomic data.
• Transmission Dynamics: Uncovered that the Malawian outbreak involved simultaneous circulation in patients, the hospital environment, and local rivers, while the South African outbreak was driven by inter-hospital patient transfer.
• Resistance Mechanism: Identified a novel mechanism for the spread of resistance determinants via plasmid cointegration (fusion of IncC and IncHI2 plasmids), explaining how identical resistance genes are carried on different plasmid backbones in different geographic clades.
• Surveillance Gap Highlight: Demonstrated the critical disparity in genomic surveillance capacity between South Africa (national system) and Malawi (research-dependent), emphasizing the risk of undetected AMR spread in low-resource settings.

4. Key Results

A. Genomic Epidemiology & Phylogeny

• Dominance of ST335: Of 345 global S. Isangi genomes, 224 (65%) belonged to Sequence Type 335 (ST335). 99% of ST335 isolates originated from Malawi and South Africa.
• Clade Structure:
  • Malawi: A single ST335 clade (Lineage 5) caused the outbreak. Genetically indistinguishable isolates were found in neonatal patients, the hospital environment, and river water downstream of the hospital.
  • South Africa: The outbreak was caused by a distinct ST335 clade (Lineage 4), though Lineage 5 was also present. Transmission reconstruction confirmed repeated inter-hospital spread.
  • Evolutionary Link: The Malawian clade is nested within a larger South African clade, suggesting a South African origin for the Malawian sub-clade.

B. Antimicrobial Resistance (AMR)

• XDR Profile: 89% of ST335 isolates carried an XDR genotype (resistance to fluoroquinolones and third-generation cephalosporins), primarily driven by blaCTX-M-15 (ESBL) and qnrB1.
• Emerging Threats: Five non-outbreak South African isolates harbored additional resistance to carbapenems (blaNDM-1 or blaOXA-48) and macrolides.
• Plasmid Dynamics:
  • South Africa: Predominantly carried IncC plasmids.
  • Malawi: Exclusively carried IncHI2 plasmids.
  • Mechanism: Despite different plasmid backbones, the resistance gene islands were highly similar. Evidence suggests a cointegrate intermediate (a hybrid IncC-IncHI2 plasmid found in public databases) facilitated the transfer of resistance genes between these plasmid types.

C. Phenotypic Characterization

• Virulence: S. Isangi ST335 showed reduced virulence in mice (0% mortality) compared to S. Typhimurium (50% mortality). This correlates with a high number of pseudogenes in the central anaerobic metabolism pathway.
• Persistence: Despite lower systemic virulence, ST335 formed robust biofilms comparable to S. Typhimurium and showed tolerance to hospital disinfectants (bleach/chlorine), facilitating environmental persistence.

5. Significance and Implications

• Public Health Threat: XDR S. Isangi ST335 represents a severe threat in Malawi and South Africa because effective therapies (e.g., ceftriaxone) are often unavailable or inaccessible.
• Environmental Reservoirs: The detection of identical strains in hospital sinks and local rivers indicates that environmental contamination can sustain outbreaks, complicating control efforts.
• Risk of Gene Transfer: The study warns that the resistance mechanisms driving S. Isangi XDR (specifically the plasmid cointegration) could transfer to more common invasive serovars like S. Typhimurium and S. Enteritidis, potentially rendering them untreatable.
• Policy Recommendation: The authors urge for the expansion of genomic surveillance in low-income countries. Relying solely on phenotypic testing is insufficient to detect emerging resistance patterns. Equitable, tiered surveillance systems are essential to contain AMR before it becomes endemic.

Conclusion: The paper reveals that S. Isangi ST335 is a highly adaptable, hospital-adapted pathogen capable of environmental persistence and rapid resistance acquisition via plasmid recombination. Its emergence highlights the urgent need for global genomic surveillance to prevent the spread of untreatable infections in resource-limited settings.